HERTI 150 MG

What is HERTI 150 MG?

HERTI 150 MG is an anti-cancer medicine containing Erlotinib as its active ingredient. It belongs to the class of drugs called tyrosine kinase inhibitors (TKIs). HERTI 150 MG works by blocking the epidermal growth factor receptor (EGFR) on cancer cells, which helps stop their growth and spread.

It is mainly used in the treatment of non-small cell lung cancer (NSCLC) and advanced pancreatic cancer.

---

What is the Use of HERTI 150 MG?

HERTI 150 MG is prescribed for:

• Non-Small Cell Lung Cancer (NSCLC): Especially in patients with EGFR mutation-positive tumors.

• Pancreatic Cancer: Used in combination with other chemotherapy drugs like gemcitabine.

---

Benefits of HERTI 150 MG

• Targeted therapy: Specifically blocks cancer cell growth without damaging normal cells.

• Improves survival rate: Shown to prolong progression-free survival in EGFR mutation-positive patients.

• Oral administration: Convenient tablet form for home-based treatment.

• Reduces tumor size and delays spread of cancer.

---

How HERTI 150 MG Works

HERTI (Erlotinib) blocks EGFR tyrosine kinase, a protein responsible for triggering signals that make cancer cells grow and divide. By inhibiting this receptor, HERTI helps slow down or stop the spread of cancer.

---

Side Effects of HERTI 150 MG

Common Side Effects:

• Skin rash

• Diarrhea

• Nausea and vomiting

• Fatigue

• Loss of appetite

• Mouth sores

Serious Side Effects (seek medical attention):

• Breathing difficulties or severe cough

• Liver problems (yellowing of eyes/skin)

• Eye irritation or vision changes

• Severe skin reactions

---

Precautions & Warnings

• Take only under medical supervision.

• Avoid pregnancy and breastfeeding while on treatment.

• Avoid exposure to sunlight; use sunscreen to prevent rash.

• Do not smoke, as it reduces the effectiveness of Erlotinib.

• Regular liver and kidney function tests are recommended.

---

Storage & Administration

• Store at room temperature (below 30°C), protected from moisture and light.

• Take exactly as prescribed by your oncologist, preferably 1 hour before or 2 hours after a meal.

---

Product Summary

• Product Name: HERTI 150 MG Tablet

• Salt Name: Erlotinib

• Strength: 150 mg

• Manufacturer: Hetero Healthcare Ltd.

• Storage: Store below 30°C, in a cool, dry place away from light

• Presentation: Strip of tablets for oral use

1. What is HERTI 150 MG used for?
It is used to treat non-small cell lung cancer and pancreatic cancer.

2. What is the active ingredient in HERTI 150 MG?
The active ingredient is Erlotinib.

3. How does HERTI 150 MG work?
It blocks EGFR receptors to stop signals that promote cancer cell growth.

4. How should I take HERTI 150 MG?
Take it orally on an empty stomach, 1 hour before or 2 hours after meals.

5. Can HERTI 150 MG be taken with food?
No, food can affect absorption; take it on an empty stomach.

6. What are the common side effects?
Rash, diarrhea, fatigue, nausea, and appetite loss are common.

7. Does HERTI 150 MG cause skin problems?
Yes, a mild skin rash is common; protect skin from sunlight.

8. Can smokers take HERTI 150 MG?
Smoking reduces its effectiveness — avoid smoking during treatment.

9. Is HERTI 150 MG safe during pregnancy?
No, it should not be used during pregnancy or breastfeeding.

10. Can HERTI 150 MG be combined with chemotherapy?
Yes, it can be used with drugs like gemcitabine for pancreatic cancer.

11. What should I do if I miss a dose?
Skip the missed dose if it’s almost time for the next one; don’t double it.

12. Can I drink alcohol while taking HERTI 150 MG?
It’s best to avoid alcohol, as it may increase side effects or liver strain.

13. How should I store HERTI 150 MG?
Store below 30°C, protected from moisture and sunlight.

14. What precautions should I take?
Avoid smoking, limit sun exposure, and report breathing issues immediately.

15. Who manufactures HERTI 150 MG?
It is manufactured by Hetero Healthcare Ltd., a trusted pharmaceutical company.